Skip to content

Clinical trials

Cardiomyopathies trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Not applicable Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20141
20161
20171
20191
20201
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Unknown status2
Active, not recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ancora Heart, Inc.2
Assistance Publique Hopitaux De Marseille2
Adverum Biotechnologies, Inc.1
Assistance Publique - Hôpitaux de Paris1
Biosense Webster, Inc.1
Central Hospital, Nancy, France1
EBR Systems, Inc.1
Rennes University Hospital1
University Hospital, Bordeaux1
University Hospital, Montpellier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies12
Heart Failure3
Atrial Fibrillation2
Cardiomyopathy, Dilated1
Cardiovascular Diseases1
Death, Sudden1
Diabetes Mellitus, Type 21
Friedreich Ataxia1
Ischemic Stroke1
Muscular Dystrophy, Duchenne1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.